Stem Cell Transplant Conditions and Indications

When is a stem cell transplant necessary? Discover the specific blood cancers (Leukemia, Lymphoma) and genetic disorders treated at Liv Hospital's advanced hematology center.

When Is It Necessary?

A stem cell transplant is a powerful, often curative treatment, but it is not suitable for every patient or every condition. It is a major medical procedure reserved for specific diseases where the potential for a cure or long-term remission outweighs the risks. At Liv Hospital, our multidisciplinary tumor board evaluates every case individually to determine if a transplant is the right path forward.

For international patients, understanding the specific indications the medical reasons to perform a transplant is the first step. Generally, a transplant is recommended when the bone marrow has failed, or when a blood cancer is aggressive, has returned after treatment (relapsed), or has a high risk of returning (high-risk features).

Which types of blood cancer are treated with stem cell transplants?

Blood cancers are the most common reason for a stem cell transplant. However, the type of transplant (Autologous vs. Allogeneic) depends on the specific disease.

1. Acute Leukemias (AML and ALL)

Acute Myeloid Leukemia (AML) and Acute Lymphoblastic Leukemia (ALL) are aggressive cancers that start in the bone marrow.

• Indication: An allogeneic transplant is often the standard of care for patients with high-risk genetic markers (like FLT3 mutation or Philadelphia chromosome) or those who do not achieve a deep remission with chemotherapy alone. It is the only potential cure for many high-risk leukemias.

2. Chronic Leukemias (CML and CLL)

Chronic Myeloid Leukemia (CML) is now often managed with targeted oral therapies (TKIs), but a transplant remains a curative option for patients who develop resistance to these drugs or progress to a "blast crisis."

3. Lymphomas (Hodgkin and Non-Hodgkin)

For Hodgkin Lymphoma and Non-Hodgkin Lymphoma (NHL), a transplant is typically indicated if the disease returns (relapsed) after initial chemotherapy or is "refractory" (does not respond).

Indication: An autologous transplant is the standard "second-line" treatment for relapsed Diffuse Large B-Cell Lymphoma (DLBCL) and Hodgkin Lymphoma.

4. Multiple Myeloma

Multiple Myeloma is a cancer of the plasma cells.

Indication: An autologous transplant is considered the standard of care for eligible, newly diagnosed patients. While not always curative, it significantly extends survival and the period of remission.

What are the primary indications for a hematopoietic stem cell transplant?

The indications for a hematopoietic stem cell transplant (HSCT) are broadly categorized into two groups: malignant (cancerous) diseases and non-malignant (benign or genetic) disorders.

In malignant diseases, the transplant allows for the use of high-dose chemotherapy to kill cancer cells, followed by a "rescue" with new stem cells. In allogeneic transplants (using a donor), it also provides a new immune system to fight the cancer. In non-malignant diseases, the goal is to replace a faulty bone marrow factory with a healthy one.

Can stem cell transplants cure non-cancerous blood disorders?

Yes. One of the most remarkable advances in hematology is the ability to cure lifelong genetic disorders.

• Sickle Cell Disease & Thalassemia Major: These are genetic conditions where the body produces abnormal hemoglobin. An allogeneic transplant replaces the patient's defective marrow with healthy donor marrow, effectively curing the disease and eliminating the need for lifelong blood transfusions and pain crises.
• Severe Aplastic Anemia: A condition where the bone marrow simply stops producing blood cells. For young patients with a matched sibling donor, a transplant is the treatment of choice and is often curative.
• Primary Immunodeficiency Disorders: Conditions where a child is born with a missing or broken immune system (like SCID). A transplant can build a new, functioning immune system.

What are the eligibility criteria for a transplant at Liv Hospital?

Having a condition listed above does not automatically make a patient a candidate for transplant. The patient's body must be strong enough to withstand the "conditioning" chemotherapy. At Liv Hospital, we use rigorous international criteria to ensure safety:

• Physiological Age: While we have successfully transplanted patients over 70, the biological "fitness" is more important than chronological age.
• Organ Function: The heart, lungs, kidneys, and liver must function above a certain threshold. We use ECHO and PFT tests to confirm this.
• Performance Status: Patients should be active and able to perform daily tasks (ECOG score of 0-1 is ideal).
• Infection Status: Active, uncontrolled infections (like severe fungal pneumonia) must be treated before the transplant can begin.

For international patients, we request recent medical reports to perform a "pre-eligibility" assessment before travel.

When is a transplant considered "urgent"?

In some cases, time is critical.

• Acute Leukemia: If a patient with AML achieves remission, the "window of opportunity" for a transplant is often narrow. Delaying can allow the leukemia to return.
• Bone Marrow Failure: In severe Aplastic Anemia, the risk of fatal infection is high, making an urgent transplant necessary as soon as a donor is found.

Liv Hospital’s International Patient Center prioritizes these cases, expediting the donor search (HLA typing) and visa processes to start treatment immediately.